MarketInOut Stock Screener Log In | Sign Up

AFT Pharmaceuticals Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/26/2026
AFT Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization380.7 mln
Float30.49 mln
Earnings Date11/20/2026

EPS

0.12
Overpriced

P / E

30.75
Overvalued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-1.75
Likely manipulated

Relative Strength

90 / 100
Top performer

Debt / Equity

0.49
Low leverage

Business Description

Founded in Auckland in 1997, AFT Pharmaceuticals develops and sells a wide range of medicines and health products across New Zealand, Australia, Asia, and other global markets. Their portfolio covers everyday health needs such as pain relief, skin care, eye care, and cold and flu treatments, as well as hospital-grade and prescription medications. The company is also working with Belgium-based Hyloris Pharmaceuticals to create a new injectable treatment for iron deficiency.

Key Fundamentals

EPS0.12
P/E30.75
ROE14.39
RPS1.97
ROIC11.62
ROA7.91
Interest Cover10.00
EBITDA, mln24.58
EV / EBITDA17.74
EV / EBIT20.44
Revenue, mln226
EV / Revenue1.95

Quote Details

Last 3.72
Change 0.09 (2.48%)
Open 3.66
Volume 27
Turnover 100.44
Average Volume 2,338.24

Financial Ratios

Pre-Tax Profit Margin9
Leverage Ratio1.97
Current Ratio2.24
Price / Book4.13
Price / Tangible Book10.24
Debt / Equity0.49
Price / Sales1.77
PEG Ratio2.42

Financial Strength

Altman Z-Score4.74
Piotroski F-Score 4 / 9
Beneish M-Score-1.75
Price to Intrinsic Value2.30
Price to Lynch Fair Value2.32
Price to Graham Number3.74
Shiller PE Ratio85.77

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.92% 83 / 100   
1 Month 6.59% 90 / 100   
2 Months 12.73% 87 / 100   
6 Months 21.57% 92 / 100   
1 Year 61.74% 94 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog